P-57 Atezolizumab in combination with bevacizumab in patients with unresectable HCC previously untreated with systemic therapy: Interim analysis results from phase IIIb Italian AMETHISTA trial
Titel:
P-57 Atezolizumab in combination with bevacizumab in patients with unresectable HCC previously untreated with systemic therapy: Interim analysis results from phase IIIb Italian AMETHISTA trial
Auteur:
Martinelli, E. Masi, G. Piscaglia, F. Cabibbo, G. Di Maio, M. Gasbarrini, A. Iavarone, M. Pellegrini, E. Mazzaferro, V. Ballestrero, A. Garufi, C. Bergamo, F. Celsa, C. Marino, D. Tovoli, F. Ponziani, F. Pressiani, T. Astolfi, C. Ciardiello, F. Daniele, B. Rimassa, L.